Tag: Prescription Drugs
Sotagliflozin Linked to Improved Glycemic Control in T1DM
Primary end point achieved by more patients with type 1 diabetes receiving any insulin therapy
Exenatide Doesn’t Up Cardiovascular Risk in T2DM
Exenatide found to be non-inferior to placebo with respect to safety for patients with type 2 diabetes
Antireflux Surgery Has High Rate of Recurrent Disease
Nearly 18 percent have recurrence requiring long-term medication, secondary surgery
Panic Disorder, GAD Not Linked to Adverse Pregnancy Outcomes
Benzodiazepines and serotonin reuptake inhibitors can slightly shorten the duration of gestation
Warfarin, Rivaroxaban Similarly Safe, Effective
Findings among cases of mild atrial fibrillation-related acute ischemic stroke
Adjuvant Nivolumab Tops Ipilimumab in Melanoma
Longer recurrence-free survival for stage IIIB, IIIC, IV melanoma
Mepolizumab Beneficial in COPD With Eosinophilic Phenotype
Lower annual rate of moderate, severe exacerbations for patients receiving 100 mg mepolizumab
Dabrafenib, Trametinib Beneficial in Resected Melanoma
Rate of relapse-free survival up for resected stage III melanoma with BRAF V600E, V600K mutations
Risk of Prematurity, SGA Up for Women on Antiepileptic Drugs
Increased risk for women on AEDs for epilepsy or other indications; risk varies with drug used
Longer Progression-Free Survival for Durvalumab in NSCLC
Longer median progression-free survival from randomization, higher response rate with durvalumab
